Format

Send to

Choose Destination
See comment in PubMed Commons below
J Clin Psychiatry. 1991 May;52(5):221-33.

The role of pimozide in clinical psychiatry: a review.

Author information

1
Department of Psychiatry, College of Physicians & Surgeons, Columbia University, New York, N.Y.

Abstract

Pimozide, a diphenylbutylpiperidine neuroleptic which is FDA-approved as a backup treatment for Gilles de la Tourette's syndrome, has been used abroad for many years as a treatment of schizophrenia and has been recently reported to be particularly effective in treating monosymptomatic hypochondriacal psychosis and delusional jealousy. Pimozide may also have a role in the treatment of negative schizophrenic symptoms, pain syndromes, and obsessive compulsive disorder. After reviewing the relevant clinical literature supporting these indications, the authors review preclinical studies that provide points of departure regarding biochemical mechanisms underlying this unique therapeutic profile.

Comment in

PMID:
2033030
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center